to accelerate the manufacturing and availability of a low-cost COVID therapeutic to populations in low- and middle-income countries
- Funded by Gates Foundation
- Total publications:0 publications
Grant number: INV-049853
Grant search
Key facts
Disease
COVID-19start year
2022Known Financial Commitments (USD)
$2,066,702Funder
Gates FoundationPrincipal Investigator
N/A
Research Location
IndiaLead Research Institution
Macleods Pharmaceuticals LtdResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Therapeutics logistics and supply chains and distribution strategies
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
N/A